News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Payne Joseph E
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2021 |
4
| Payne Joseph E (Director) has filed a Form 4 on Vallon Pharmaceuticals, Inc.|
Txns:
| Bought 10,700 shares
@ $3.85, valued at
$41.2k
Bought 6,800 shares
@ $4.5, valued at
$30.6k
|
|
| 05/18/2021 |
4
| Payne Joseph E (Director) has filed a Form 4 on Vallon Pharmaceuticals, Inc.|
Txns:
| Granted 15,000 options to buy
@ $3.66, valued at
$54.9k
Granted 14,286 options to buy
@ $3.66, valued at
$52.3k
|
|
| 02/10/2021 |
3
| Payne Joseph E (10% Owner) has filed a Form 3 on Vallon Pharmaceuticals, Inc. |
| 12/22/2020 |
4
| Payne Joseph E (President and CEO) has filed a Form 4 on Arcturus Therapeutics Holdings Inc.|
Txns:
| Granted 175,000 options to buy
@ $99.29, valued at
$17.4M
|
|
| 06/10/2020 |
4
| Payne Joseph E (President and CEO) has filed a Form 4 on Arcturus Therapeutics Holdings Inc.|
Txns:
| Bought 1,000 shares
@ $31.69, valued at
$31.7k
|
|
| 02/20/2020 |
4
| Payne Joseph E (President and CEO) has filed a Form 4 on Arcturus Therapeutics Holdings Inc.|
Txns:
| Granted 100,000 options to buy
@ $14.12, valued at
$1.4M
|
|
| 08/30/2019 |
4
| Payne Joseph E (President and CEO) has filed a Form 4 on Arcturus Therapeutics Holdings Inc.|
Txns:
| Bought 5,000 shares
@ $11.22, valued at
$56.1k
|
|
| 02/11/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/02/2019 |
3
| Payne Joseph E (President and CEO) has filed a Form 3 on Arcturus Therapeutics Ltd. |
| 11/20/2018 |
SC 13D/A
| Payne Joseph E reports a 13.7% stake in Arcturus Therapeutics Ltd. |
| 05/23/2018 |
SC 13D/A
| Payne Joseph E reports a 13.7% stake in Arcturus Therapeutics Ltd. |
| 05/14/2018 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 05/02/2018 |
SC 13D/A
| Payne Joseph E reports a 13.7% stake in Arcturus Therapeutics Ltd. |
| 04/23/2018 |
SC 13D/A
| Payne Joseph E reports a 13.7% stake in Arcturus Therapeutics Ltd. |
| 04/13/2018 |
SC 13D/A
| Payne Joseph E reports a 13.7% stake in Arcturus Therapeutics Ltd. |
| 04/04/2018 |
SC 13D/A
| Payne Joseph E reports a 13.7% stake in Arcturus Therapeutics Ltd. |
| 02/13/2018 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/06/2018 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
|
|